Tag Archives: specialty drug costs

Specialty drug costs will continue to grow and  dominate a plan sponsors’ drug spend if left unchecked (expected to grow from approx. 20-25% today to 45% of drug spend by 2030).  Surprisingly, as many as 50% of all Rx plan sponsors have not yet acted to implement a coordinated Specialty Drug Strategy(“SDS”).  At WBC (wbcbaltimore.com) we’ve created a […]